05 March 2020
Russia will speed up development of a vaccine against the novel coronavirus, Russian Deputy Prime Minister Tatyana Golikova said during a meeting between President Vladimir Putin and members of the Russian government on March 4.
“Currently, the State Research Center of Virology and Biotechnology “VECTOR” located in the Novosibirsk Region is working on developing vaccines against the novel coronavirus infection, working on 13 variants in 5 areas. We are trying to speed up the development of these drugs to the extent possible,” she said.
WHO declared the outbreak of the novel coronavirus a global health emergency and named the virus COVID-19. Cases of coronavirus have been reported in over 70 countries, including Russia. The largest outbreaks of COVID-19 outside of China have been detected in South Korea, Iran and Italy.
According to WHO, the number of people infected with COVID-19 outside of China is nearing 10,500, with over 160 people dead.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
InFigures European Pharma Hotspots 2024
05 November 2024
Federal project to combat hepatitis C will be launched in 2025
05 November 2024
Federal project to combat hepatitis C will be launched in 2025
01 November 2024
Domestic drugs now make up 60% of Russian pharmacies
01 November 2024